Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (33)
Xiaojiang Li, Yuzhuo Bai, Ke Feng, Zhendong Chu, Haijun Li, Zhicheng Lin & Lin Tian. (2023) Therapeutic, diagnostic and prognostic values of TRIM proteins in prostate cancer. Pharmacological Reports 75:6, pages 1445-1453.
Crossref
Crossref
Rachel Lawrence, Melissa Watters, Caitlin R. Davies, Klaus Pantel & Yong-Jie Lu. (2023) Circulating tumour cells for early detection of clinically relevant cancer. Nature Reviews Clinical Oncology 20:7, pages 487-500.
Crossref
Crossref
Vera Constâncio, Nuno Tiago Tavares, Rui Henrique, Carmen Jerónimo & João Lobo. (2022) MiRNA biomarkers in cancers of the male reproductive system: Are we approaching clinical application?. Andrology 11:4, pages 651-667.
Crossref
Crossref
Jinghe Ye, Mao Wu, Long He, Peng Chen, Hongtao Liu & Hongwei Yang. (2023)
Glutathione-S-Transferase
Gene Promoter Methylation in Cell-Free DNA as a Diagnostic and Prognostic Tool for Prostate Cancer: A Systematic Review and Meta-Analysis
. International Journal of Endocrinology 2023, pages 1-9.
Crossref
Crossref
Vahid Yaghoubi Naei, Pritam Bordhan, Fatemeh Mirakhorli, Motahare Khorrami, Jesus Shrestha, Hojjatollah Nazari, Arutha Kulasinghe & Majid Ebrahimi Warkiani. (2023) Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA. Therapeutic Advances in Medical Oncology 15.
Crossref
Crossref
Neeraj Chauhan, Anjali Manojkumar, Meena Jaggi, Subhash C. Chauhan & Murali M. Yallapu. (2022) microRNA-205 in prostate cancer: Overview to clinical translation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:6, pages 188809.
Crossref
Crossref
Yuhan Wang, Humin Zhang, Huang Li, Jie Xiong, Jie Wang & Yuanshuai Huang. (2022) Application of tumor-educated platelets as new fluid biopsy markers in various tumors. Clinical and Translational Oncology 25:1, pages 114-125.
Crossref
Crossref
Umang Swami, Nicolas Sayegh, Yeonjung Jo, Benjamin Haaland, Taylor R. McFarland, Roberto H. Nussenzveig, Divyam Goel, Deepika Sirohi, Andrew W. Hahn, Benjamin L. Maughan, Amir Goldkorn & Neeraj Agarwal. (2022) External validation of association of baseline circulating tumor cell counts with survival outcomes in men with metastatic castration-sensitive prostate cancer.. Molecular Cancer Therapeutics.
Crossref
Crossref
Felice Crocetto, Gianluca Russo, Erika Di Zazzo, Pasquale Pisapia, Benito Fabio Mirto, Alessandro Palmieri, Francesco Pepe, Claudio Bellevicine, Alessandro Russo, Evelina La Civita, Daniela Terracciano, Umberto Malapelle, Giancarlo Troncone & Biagio Barone. (2022) Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives. Cancers 14:13, pages 3272.
Crossref
Crossref
Arpit Rao, Nagaishwarya Moka, Daniel A. Hamstra & Charles J. Ryan. (2022) Co-Inhibition of Androgen Receptor and PARP as a Novel Treatment Paradigm in Prostate Cancer—Where Are We Now?. Cancers 14:3, pages 801.
Crossref
Crossref
Olga Golubnitschaja, Peter Kubatka, Alena Mazurakova, Marek Samec, Abdullah Alajati, Frank A. Giordano, Vincenzo Costigliola, Jörg Ellinger & Manuel Ritter. (2022) Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper. Cancers 14:3, pages 675.
Crossref
Crossref
Maija Puhka, Lisse Thierens, Daniel Nicorici, Tarja Forsman, Tuomas Mirtti, Taija af Hällström, Elina Serkkola & Antti Rannikko. (2022) Exploration of Extracellular Vesicle miRNAs, Targeted mRNAs and Pathways in Prostate Cancer: Relation to Disease Status and Progression. Cancers 14:3, pages 532.
Crossref
Crossref
Seyed Mohammad Kazem Aghamir, Keykavos Gholami & Florence Le Calvez-Kelm. 2022. Liquid Biopsy in Urogenital Cancers and its Clinical Utility. Liquid Biopsy in Urogenital Cancers and its Clinical Utility
31
43
.
Seyed Mohammad Kazem Aghamir, Amirhossein Rahimnia, Seyed Saeed Tamehri Zadeh & Hassan Roudgari. 2022. Liquid Biopsy in Urogenital Cancers and its Clinical Utility. Liquid Biopsy in Urogenital Cancers and its Clinical Utility
67
99
.
Vera Constâncio, Rui Henrique & Carmen Jerónimo. 2022. MicroRNA in Human Malignancies. MicroRNA in Human Malignancies
291
299
.
Nikolas H. Stoecklein & Rui P. L. Neves. 2022. Cancer Metastasis Through the Lymphovascular System. Cancer Metastasis Through the Lymphovascular System
139
146
.
Verena Lieb, Amer Abdulrahman, Katrin Weigelt, Siegfried Hauch, Michael Gombert, Juan Guzman, Laura Bellut, Peter J. Goebell, Robert Stöhr, Arndt Hartmann, Bernd Wullich, Helge Taubert & Sven Wach. (2021) Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients. Cells 10:11, pages 3223.
Crossref
Crossref
Bo Zhao & Chunlei Tu. (2021) Research and Development of Inventory Management and Human Resource Management in ERP. Wireless Communications and Mobile Computing 2021, pages 1-12.
Crossref
Crossref
Sudeh Izadmehr, Dara J. Lundon, Nihal Mohamed, Andrew Katims, Vaibhav Patel, Benjamin Eilender, Reza Mehrazin, Ketan K. Badani, John P. Sfakianos, Che-Kai Tsao, Peter Wiklund, William K. Oh, Carlos Cordon-Cardo, Ashutosh K. Tewari, Matthew D. Galsky & Natasha Kyprianou. (2021) The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic. Frontiers in Oncology 11.
Crossref
Crossref
Heidi Fettke, Edmond M. Kwan, Patricia Bukczynska, Jason A. Steen, Maria Docanto, Nicole Ng, Phillip Parente, Andrew Mant, Siavash Foroughi, Carmel Pezaro, Christine Hauser, Tu Nguyen‐Dumont, Melissa C. Southey & Arun A. Azad. (2021) Independent prognostic impact of plasma NCOA2 alterations in metastatic castration‐resistant prostate cancer. The Prostate 81:13, pages 992-1001.
Crossref
Crossref
Emmy Boerrigter, Guillemette E. Benoist, Inge M. van Oort, Gerald W. Verhaegh, Onno van Hooij, Levi Groen, Frank Smit, Irma M. Oving, Pieter de Mol, Tineke J. Smilde, Diederik M. Somford, Niven Mehra, Jack A. Schalken & Nielka P. van Erp. (2021) Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and prednisone treatment. Molecular Oncology 15:9, pages 2453-2465.
Crossref
Crossref
Esther Campos-Fernández, Nathalia Oliveira Alqualo, Lorrayne Cristina Moura Garcia, Caroline Coutinho Horácio Alves, Tábatha Danielle Ferreira Arantes Vieira, Danilo Caixeta Moreira & Vivian Alonso-Goulart. (2021) The use of aptamers in prostate cancer: A systematic review of theranostic applications. Clinical Biochemistry 93, pages 9-25.
Crossref
Crossref
Mafalda Antunes‐Ferreira, Danijela Koppers‐Lalic & Thomas Würdinger. (2020) Circulating platelets as liquid biopsy sources for cancer detection. Molecular Oncology 15:6, pages 1727-1743.
Crossref
Crossref
Thais Pereira-Veiga, Miriam González-Conde, Luis León-Mateos, Roberto Piñeiro-Cid, Carmen Abuín, Laura Muinelo-Romay, Mónica Martínez-Fernández, Jenifer Brea Iglesias, Jorge García González, Urbano Anido, Santiago Aguín-Losada, Víctor Cebey, Clotilde Costa & Rafael López-López. (2021) Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers. Clinical & Experimental Metastasis 38:2, pages 239-251.
Crossref
Crossref
Samanta Salvi, Erika Bandini, Silvia Carloni, Valentina Casadio, Michela Battistelli, Sara Salucci, Ilaria Erani, Emanuela Scarpi, Roberta Gunelli, Giacomo Cicchetti, Michele Guescini, Massimiliano Bonafè & Francesco Fabbri. (2021) Detection and Investigation of Extracellular Vesicles in Serum and Urine Supernatant of Prostate Cancer Patients. Diagnostics 11:3, pages 466.
Crossref
Crossref
Paweł Porzycki. (2021) Potencjalne kliniczne zastosowanie cząsteczek miRNA w diagnostyce raka prostaty. Postępy Higieny i Medycyny Doświadczalnej 75:1, pages 491-501.
Crossref
Crossref
Michelle Davey, Sami Benzina, Marc Savoie, Guy Breault, Anirban Ghosh & Rodney J. Ouellette. (2020) Affinity Captured Urinary Extracellular Vesicles Provide mRNA and miRNA Biomarkers for Improved Accuracy of Prostate Cancer Detection: A Pilot Study. International Journal of Molecular Sciences 21:21, pages 8330.
Crossref
Crossref
Nidhi Shukla, Narmadhaa Siva, Babita Malik & Prashanth Suravajhala. (2020) Current Challenges and Implications of Proteogenomic Approaches in Prostate Cancer. Current Topics in Medicinal Chemistry 20:22, pages 1968-1980.
Crossref
Crossref
Jacob J. K. Carson, Michael A. Di Lena, David M. Berman, D. Robert Siemens & Christopher R. Mueller. (2020) Development and initial clinical correlation of a DNA methylation‐based blood test for prostate cancer. The Prostate 80:12, pages 1038-1042.
Crossref
Crossref
Magdalena Żmigrodzka, Olga Witkowska-Piłaszewicz & Anna Winnicka. (2020) Platelets Extracellular Vesicles as Regulators of Cancer Progression—An Updated Perspective. International Journal of Molecular Sciences 21:15, pages 5195.
Crossref
Crossref
Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto & Chikara Ohyama. (2020) Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer. IJU Case Reports 3:4, pages 141-144.
Crossref
Crossref
Renee Brady-Nicholls, John D. Nagy, Travis A. Gerke, Tian Zhang, Andrew Z. Wang, Jingsong Zhang, Robert A. Gatenby & Heiko Enderling. (2020) Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation. Nature Communications 11:1.
Crossref
Crossref
Jacob Fredsøe, Anne K. I. Rasmussen, Peter Mouritzen, Marianne T. Bjerre, Peter Østergren, Mikkel Fode, Michael Borre & Karina D. Sørensen. (2020) Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential. Diagnostics 10:4, pages 188.
Crossref
Crossref